Frontiers in Cardiovascular Medicine (Dec 2023)

Comprehensive review on gene mutations contributing to dilated cardiomyopathy

  • Shipeng Wang,
  • Zhiyu Zhang,
  • Jiahuan He,
  • Junqian Liu,
  • Xia Guo,
  • Haoxuan Chu,
  • Hanchi Xu,
  • Yushi Wang

DOI
https://doi.org/10.3389/fcvm.2023.1296389
Journal volume & issue
Vol. 10

Abstract

Read online

Dilated cardiomyopathy (DCM) is one of the most common primary myocardial diseases. However, to this day, it remains an enigmatic cardiovascular disease (CVD) characterized by ventricular dilatation, which leads to myocardial contractile dysfunction. It is the most common cause of chronic congestive heart failure and the most frequent indication for heart transplantation in young individuals. Genetics and various other factors play significant roles in the progression of dilated cardiomyopathy, and variants in more than 50 genes have been associated with the disease. However, the etiology of a large number of cases remains elusive. Numerous studies have been conducted on the genetic causes of dilated cardiomyopathy. These genetic studies suggest that mutations in genes for fibronectin, cytoskeletal proteins, and myosin in cardiomyocytes play a key role in the development of DCM. In this review, we provide a comprehensive description of the genetic basis, mechanisms, and research advances in genes that have been strongly associated with DCM based on evidence-based medicine. We also emphasize the important role of gene sequencing in therapy for potential early diagnosis and improved clinical management of DCM.

Keywords